---
document_datetime: 2023-09-21 17:07:48
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/yescarta-epar-all-authorised-presentations_en.pdf
document_name: yescarta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7750234
conversion_datetime: 2025-12-28 00:33:35.462708
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Annex A

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength                    | Pharmaceutical Form     | Route of Administration   | Immediate Packaging          | Content (concentration)   | Pack size   |
|------------------|-------------------|-----------------------------|-------------------------|---------------------------|------------------------------|---------------------------|-------------|
| EU/1/18/1299/001 | YESCARTA          | 0.4 x 10 8 - 2 x 10 8 cells | Dispersion for infusion | Intravenous use           | bag (ethylene vinyl acetate) | 68 ml                     | 1 bag       |